Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Datamonitor
|
$175.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Asahi Kasei Corporation's Subsidiary Completes Takeover Bid of ZOLL Medical Corporation's Shares; Announces Merger of Subsidiary and Sub-subsidiary
Asahi Kasei Corporation announced that its America-based subsidiary, has purchased 20,916,921 shares of ZOLL Medical Corporation's common stock, at the price of USD 93 per share, through takeover bid during the period from March 26, 2012 to April 20, 2012. After the transaction, the America-based subsidiary holds a total of 100% stake in ZOLL Medical. After that, the Company also decided on the merger of the America-based subsidiary and ZOLL Medical Corporation. After the transaction, ZOLL Medical will be the surviving company and the America-based subsidiary will be dissolved. ZOLL Medical will become a wholly owned subsidiary of the Company.
Latest Developments for Asahi Kasei Corp
- R&I Affirms Rating on Asahi Kasei Corp at "AA-"; Rating Outlook Stable
- Asahi Kasei Corp Completes Subsequent Offering Period For ZOLL Medical Corp
- Asahi Kasei Corporation Commences Tender Offer For ZOLL Medical Corporation
- Asahi Kasei Corporation To Buy ZOLL Medical Corporation For Up To JPY100 Billion-DJ
Latest Key Developments in Chemicals
- Share this
- Link this
- Digg this
Follow Reuters